title: Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine-Gass syndrome: a prospective case series.
abstract: PurposeTo determine the preliminary efficacy and safety of off-label dexamethasone implant for treatment of recurrent cystoid macular edema (CME) secondary to Irvine-Gass syndrome (IGS).Patients and methodsThis study was set in Raghudeep Eye Clinic, Ahmedabad and LV Prasad Eye Institute, Hyderabad (India). It is a Prospective Case Series. Prospective case series comprising of patients with uncomplicated pseudophakia and CME due to IGS who recurred after one course of topical steroids with NSAIDS and a sub-Tenon corticosteroid injection. A complete ocular and systemic exam, fluorescein angiography, and central subfield thickness (CST) on optical coherence tomography scans were performed. Follow-up visits were on days 1, 15, and 30 and then monthly for a year. Appropriate statistical analysis was done. The primary outcome measure was the change in CDVA at months 1, 6, and 12. Secondary outcome measures were recurrence of CME and complications if any as noted at months 1, 2, 6, and 12.ResultsAbout 27 patients (27 eyes) with 16 males were included. Median age: 63.24±5.62 years. At 1 month, the CDVA improved to 0.04±0.02 (20/25) logMAR from 0.52±0.12 logMAR (20/70) (P=0.001) with a reduction in CST from 454.2±45.3 to 218.32±38.15 microns(P=0.013). The CDVA was 0.04±0.03 logMAR(P<0.001) at month 6 and 0.05±0.02 logMAR(P<0.001) at month 12. The CST was 221±35.2 microns (P=0.013) at month 6 and 214±43.34 microns (P=0.0124) at month 12. All improvements were maintained for a year. Only one patient required a second injection. No complications were noted.ConclusionThe implant is safe and effective for the treatment of recurrent CME due to IGS.
authors.affiliation: Department of Vitreoretinal Surgery, Sudhalkar Eye Hospital and Retina Centre, Baroda, India.|Raghudeep Eye Hospital, Ahmedabad, India.
authors.forename: A
authors.initials: A
authors.lastname: Sudhalkar
authors.affiliation: LV Prasad Eye Hospital, Hyderabad, India.
authors.forename: J
authors.identifier: http://orcid.org/0000-0003-1772-3558
authors.initials: J
authors.lastname: Chhablani
authors.affiliation: Raghudeep Eye Hospital, Ahmedabad, India.
authors.forename: A
authors.initials: A
authors.lastname: Vasavada
authors.affiliation: Raghudeep Eye Hospital, Ahmedabad, India.
authors.forename: D
authors.initials: D
authors.lastname: Bhojwani
authors.affiliation: Raghudeep Eye Hospital, Ahmedabad, India.
authors.forename: V
authors.initials: V
authors.lastname: Vasavada
authors.affiliation: Raghudeep Eye Hospital, Ahmedabad, India.
authors.forename: S
authors.initials: S
authors.lastname: Vasavada
mesh_terms: D000368:Aged; D003907:Dexamethasone / Q000008:administration & dosage*; D004343:Drug Implants; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D019591:Pseudophakia / Q000188:drug therapy / Q000209:etiology; D041623:Tomography, Optical Coherence; D014792:Visual Acuity
chemical_list: D004343:Drug Implants; D005938:Glucocorticoids; D003907:Dexamethasone